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Mass spectrometry imaging (MSI) provides label-free, non-targeted molecular and spatial information 
of the biomolecules within tissue. Lipids play important roles in lung biology, e.g. as surfactant, 
preventing alveolar collapse during normal and forced respiration. Lipidomic characterization of late 
fetal mouse lungs at day 19 of gestation (E19) has not been performed yet. In this study we employed 
high-resolution atmospheric pressure scanning microprobe matrix-assisted laser desorption/ionization 
MSI for the lipidomic analysis of E19 mouse lungs. Molecular species of different lipid classes were 
imaged in E19 lung sections at high spatial and mass resolution in positive- and negative-ion mode. 
Lipid species were characterized based on accurate mass and on-tissue tandem mass spectrometry. 
In addition, a dedicated sample preparation protocol, homogenous deposition of matrices on tissue 
surfaces and data processing parameters were optimized for the comparison of signal intensities of 
lipids between different tissue sections of E19 lungs of wild type and Pex11β-knockout mice. Our study 
provides lipid information of E19 mouse lungs, optimized experimental and data processing strategies 
for the direct comparison of signal intensities of metabolites (lipids) among the tissue sections from MSI 
experiments. To best of our knowledge, this is the first MSI and lipidomic study of E19 mouse lungs.
Lipids are versatile biologically active compounds involved in important physiological and pathological pro-
cesses. Lipids are the structural integral components of the cell membranes, function as signalling molecules in 
various cellular cascades, and support energy homeostasis, based on a huge diversity of lipid species with unique 
physico-chemical properties1,2. Disruption or imbalance in lipid composition or metabolism lead to various met-
abolic disorders such as diabetes, obesity, atherosclerosis, or infectious and neurodegenerative diseases3.
Lipid composition varies significantly from organ to organ and even differs within the various cells of an 
organ4. For example, the lung is composed of more than 40 different cell types and each cell shows a distinct lipid 
distribution pattern5–7. Furthermore, type-II pneumocytes - also called alveolar epithelial cells type II (AECII) - 
synthesize and secrete via exocytosis a complex mixture of lipids and proteins into the alveolar space, forming the 
pulmonary surfactant8,9. One of the major functions of the surfactant lipids is to reduce the surface tension at the 
air-liquid interface, and thereby decrease the tendency of alveolar collapse during end-expiration9,10.
In fact, lipids account for up to 20% of dry weight of the lung tissue4. These lipids are vital in the lung and 
participate in many cellular functions. Especially, they (1) neutralize free radicals and reactive oxygen species11, 
(2) protect lungs from inhaled particles and pathogenic micro-organisms12, (3) act as a potent antiviral agent13–15 
and (4) are involved as biologically active secondary lipid messengers in the regulation of lung inflammation16. 
Indeed, abnormalities in pulmonary lipid/surfactant composition and/or metabolism are closely associated with 
various pulmonary diseases such as respiratory distress syndrome17, hyaline membrane disease18, asthma19, 
chronic obstructive pulmonary disease20, bronchiolitis21, cystic fibrosis22, pneumonia23, interstitial lung dis-
eases24, lung injury25 and cancer26.
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Several studies have analyzed the pulmonary lipid composition of different mammalian species in normal and 
diseased states4,6. The most widely used methods for lipid analysis are hyphenated analytical techniques such as 
liquid chromatography or gas chromatography coupled to mass spectrometry. Matrix-assisted laser desorption/
ionization mass spectrometry imaging (MALDI MSI) is a prominent, sensitive analytical tool, which provides 
molecular information and spatial distribution of the analytes directly from the biological specimens. MSI has 
received increasing attention, since (1) labelling is not necessary, (2) hundreds of molecules can be detected in 
a single measurement and (3) spatial distributions of biomolecules in biological tissues are provided27. From its 
introduction in 199428 until to date, this technique has been applied to visualize a broad spectrum of analytes such 
as lipids29, proteins30, peptides31, metabolites32, n-linked glycans33, drugs34 in various types of samples including 
mammalian tissues35, cells36, plant tissues37, insects38 and microbial cultures39.
A large number of studies utilized MSI techniques in lung biology, to investigate the distribution and quantify 
drugs in different types of lung cancers40, in tissues treated with several anti-tuberculosis drugs41,42 and to molec-
ularly characterize various lung cancers based on their proteomic profiles43. MSI has been applied to visualize the 
major surfactant lipid dipalmitoylphosphatidylcholine [DPPC, (PC32:0)] in human lung44 and in xenografts from 
human lung cancer cells45. Berry and colleagues developed a modified optical cutting temperature compound as 
a new inflation and embedding material to map the major phospholipid species in adult mice46 and in human 
lungs7. Carter and colleagues employed MALDI MSI as a tool for the detection of novel molecular biomarkers 
in radiation-induced lung injury47. In line with these technical developments, three-dimensional (3D) imaging 
workflows have been developed to visualize phosphatidylcholine (PC) and sphingomyelin (SM) lipid species in 
entire adult mouse lungs48.
It is apparent that characterization of molecular information (lipids, metabolites and proteins, etc.) of the 
lungs in diseased states, during fetal and postnatal stages, is a key to understand the molecular alterations dur-
ing lung development and the pathogenesis or pathophysiology of various pulmonary diseases, associated with 
these indispensable biomolecules49,50. We recently reported significant stage-specific differences in the individual 
lipid-species composition of mouse lung during postnatal pulmonary development processes49. However, so far 
no information is available on the lipidome of fetal mouse lungs, from either MSI or liquid chromatography-mass 
spectrometry.
In this study, high mass accuracy (≤2 ppm), high-resolution in mass (140,000 @ m/z 200) and space (10 µm 
per pixel) atmospheric pressure scanning microprobe MALDI MSI (AP-SMALDI MSI) was used for the first time 
to characterize the lipid profile of late fetal mouse lungs at day 19 of gestation (E19) in positive- and negative-ion 
mode. An optimized sample preparation protocol and data analysis workflow were developed for the reliable and 
reproducible relative quantification of lipids and other cellular metabolites in different tissue sections. To demon-
strate the power of our optimized method for relative comparisons of distinct lung sections with alterations in 
lipid content, knockout (KO) mice with a peroxisomal biogenesis defect (Pex11β−/−) were used in addition to 
wild type (WT) sections, as an experimental model.
Results and Discussion
MALDI MSI has become a fundamental qualitative and quantitative analytical tool for the analysis of a large vari-
ety of substances in biological specimens. The recent technological improvements in MSI such as incorporation 
of high-resolution accurate mass spectrometers (e.g. orbital trapping mass analyser), higher lateral resolution 
under close-to-physiological conditions (subcellular level, 1.4 µm spot size)51, molecular and topographical anal-
ysis of 3D surfaces52 has further advanced the field and its application value. Signal intensities of analytes in MSI 
depend on several critical parameters, such as sample handling and preparation, tissue thickness, matrix proper-
ties (choice of matrix, solvent, application method and local matrix concentration), intercomponent charge com-
petition, spatial resolution, variance in the experimental, instrumental conditions and ion suppression effects27. 
Therefore, to achieve high quality reproducible information from MSI and to compare signal intensities of ana-
lytes in a set of tissue sections, a dedicated sample preparation and data analysis strategy within the imaging 
workflow is mandatory.
In the present study, we established a sample preparation protocol for optimal tissue processing, sectioning 
and lipid profiling of E19 mouse lungs using high-resolution AP-SMALDI MSI in positive- and negative-ion 
mode. A detailed data processing framework was optimized to compare the differential expression of cellular 
metabolites in distinct tissue sections to each other. As an experimental model to eventually show differences in 
the lipid composition between distinct lung tissue sections at late fetal stage, we analyzed and compared lipids 
in different lung sections of E19 WT and Pex11β KO mice. PEX11 proteins are peroxisomal membrane proteins 
which consist of three different isoforms (PEX11α, β and γ) in mammals and play an important role in peroxiso-
mal proliferation53. Pex11β KO animals, which die immediately after birth (neonatal lethality), showed reduced 
numbers of peroxisomes and severe pathological features of Zellweger syndrome, such as developmental delay, 
hypotonia, neuronal migration defects and neuronal apoptosis53,54. The underlying molecular mechanisms of 
these pathological alterations in Pex11β KO animals are still poorly understood.
Optimized workflow for late fetal mouse lung lipidome using AP-SMALDI MSI. A scheme of an 
optimized workflow to characterize and compare lipid species directly from tissue sections of different E19 mouse 
lungs using high-resolution AP-SMALDI MSI is shown in Fig. 1. Briefly, sectioning of E19 mouse lungs, selection 
for section quality and ideal matching of section thickness, uniform deposition of matrix on tissue surfaces and 
MSI methodologies were optimized in positive- and negative-ion mode for comprehensive lipid mapping of 
E19 mouse lungs. E19 WT and Pex11β KO mouse lung MSI data sets were acquired individually under identical 
experimental and instrumental conditions. Thereafter, data sets (.raw) were converted to the common data for-
mat for MS imaging (imzML) using the in-house developed “RAW converter” version 1.1.055. The converted WT 
and Pex11β KO imzML files were stitched together using “imzML converter” version 1.356, and a detailed data 
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processing framework was optimized for comparative lipidomic analysis of E19 WT and Pex11β KO mouse lungs. 
The individual steps in the optimized workflow are described in the following.
Optimization of late fetal mouse lung tissue sectioning procedure for MSI. Sample prepa-
ration is the most crucial step in any MSI experiments. Initially, we obtained tissue sections from PFA-fixed 
OCT-embedded WT and KO E19 mouse lungs (Fig. S1A), which is the most-common tissue preparation method 
used for pulmonary histological studies. In general, OCT provides a smooth cutting surface and preserves the 
tissue architecture57. However, OCT contains benzalkonium salts as a preservative which suppress lipid ioniza-
tion and form adducts with endogenous lipid species46. Furthermore, OCT contains polyethylene glycols and 
polyvinyl alcohol polymers, often causing ion suppression and strong background signals which can severely 
interfere with MS acquisition and data interpretation. OCT and other polymeric embedding materials are thus 
not compatible with imaging studies of small molecules (e.g. lipids, metabolites). Carter and colleagues recently 
demonstrated formalin-fixation via tracheal instillation and fixative inflation of the lung followed by gelatin 
embedding for lipidomic analysis of larger mammalian (monkey) lungs58. However, this method showed loss 
of phosphatidylethanolamine (PE) and reduced signal intensities of phosphatidylserine (PS) lipid species due 
to chemical crosslinking of primary amine groups58,59. Owing of drawbacks, these methods (e.g. formalin/PFA/
agarose inflation and/or embedding with polymeric materials, etc.) are not appropriate to map the complete 
lipidome of lung tissues using MSI. Therefore, cryosectioning of tissue without using any embedding material is 
more suitable for MSI, which would aid to map a comprehensive lipidome and/or metabolome without any losses 
or chemical modifications.
The most challenging part in our approach was the preparation of E19 mouse lung cryosections for the lipid 
imaging studies. In order to detect all possible distinct lipid classes with less and/or no background signals, fresh 
frozen lung tissue was mounted with water on tissue holders for cryosectioning. 12 µm thick frozen sections 
were carefully cut and collected on a glass slide without embedding material. However, we frequently failed to 
obtain WT and KO tissue sections on a single objective slide for measuring both sections in a single experiment, 
a procedure which diminishes experimental artefacts in comparative analyses. Due to differences in lung tissue 
consistency of WT and KO sections, we often observed problems of different section quality on the same objec-
tive slide, WT sections sometimes containing a fold, or KO sections being broken several times in longitudinal 
direction (Fig. S1B). We therefore decided to mount WT and KO tissue sections on different glass slides to be 
able to select them according to their section quality and thickness. Even though always 12 µm were used as 
cutting thickness, we frequently observed variations in thickness of subsequent cryosections of the same tissue 
block of WT animals. These variations were even more pronounced due to the differences of tissue consistency 
Figure 1. Optimized MSI workflow for characterization and comparative lipidomic analysis of late fetal mouse 
lung sections at day 19 of gestation (E19) using atmospheric-pressure scanning microprobe matrix-assisted 
laser desorption/ionization mass spectrometry imaging (AP-SMALDI MSI). (A) Breeding of WT and Pex11β 
KO E19 animals53. (B) Cryosectioning of fresh snap-frozen E19 mouse lung tissues for MSI experiments using 
a cryomicrotome. (C) Optical phase contrast image of a 12 µm thick section of E19 mouse lung and selection of 
optimal sections. (D) Tissue section fixed to the sample probe. (E) Homogenous deposition of matrices using 
an automatic pneumatic ultrafine sprayer (“SMALDIPrep”). (F) MSI data acquisition using an “AP-SMALDI10” 
ion source coupled to a Q Exactive mass spectrometer. (G) MSI data sets (.raw files). (H) Characterization of 
E19 (WT) mouse lung lipidome. (I) Optimization of the data analysis workflow for comparative lipidomic 
analysis. (J) Comparison of relative signal intensities of lipids between WT and Pex11β KO E19 lung tissue 
sections.
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between WT and KO animals (Fig. S1C,D). To check the effects of section thickness on MALDI imaging analysis 
we intentionally measured sections with distinct section thickness of WT animals. Indeed, we observed a drastic 
change in signal intensities of lipids between tissue (E19 WT) sections of varying thickness (Fig. S1E,F, data not 
shown). We therefore tried to develop a quick procedure to select for similar thickness of consecutive sections of 
WT and KO mice on different glass slides using water (ice) mounted tissue blocks (Fig. S1G,H). We optimized a 
quick photographic imaging procedure and digitally created full section phase-contrast images of all cut sections 
(see materials and methods). We then carefully compared grey values reflecting the section thickness and selected 
similar grey value images of WT and KO tissue sections with optimal tissue quality (criteria mentioned in Fig. S1) 
for preselection of the best region of interest in comparable tissue areas within images by avoiding tissue foldings 
and other sectioning artefacts.
Care was also taken that the same lung lobes were used for parallel comparisons, since development and alve-
olarization is different in apical or basal lung regions60.
Lipidomic profiling of late fetal mouse lungs with high-resolution AP-SMALDI MSI. After opti-
mization of the tissue sectioning and selection procedure, lipids were characterized by scanning the E19 (WT) 
lung tissue sections at a high mass resolution (140,000 @ m/z 200) and high spatial resolution (10 µm per pixel) 
using AP-SMALDI MSI. Figure 2A,B represent a single pixel (10 µm) mass spectrum of E19 mouse lungs for 
the selected m/z range in negative- and positive-ion mode. The negative-ion mode analysis of E19 mouse lungs 
resulted in detection of different classes of lipid deprotonated species (Fig. 2A), whereas in positive-ion mode, 
mainly PC and SM lipids were observed as protonated, sodiated, or potassiated species (Fig. 2B). In general, PC, 
SM and ceramide (Cer) lipid species are predominantly ionized and detected in positive-ion mode, due to their 
quaternary amine groups, suppressing the ionization of other lipid classes. Phosphatidylglycerol (PG), PE, PS, 
phosphatidic acid (PA) and phosphatidylinositol (PI), on the other hand, are dominant in negative-ion mode61. 
Therefore, to provide comprehensive lipid information of E19 mouse lungs, MSI experiments were performed in 
both ionization modes.
In positive-ion spectra (Fig. 2B) the most intense lipid signals were observed at m/z 772.52484, 798.54028 and 
annotated as potassiated PC. The signal at m/z 772.52484 with a mass error of 0.60 ppm corresponds to potassi-
ated PC(32:0) lipid. PC(32:0) [DPPC; most probably a combination of two saturated palmitic acyl chains] is the 
major surface-active component (≈40–70% of total PC or ≈30–60% of total surfactant lipid) of the mammalian 
pulmonary lipidome and is responsible for generating a lower surface tension (close to zero mN/m) during res-
piration10,62. Protonated PC(32:0) at m/z 734.56952 (0.12 ppm) and its sodiated homologue at m/z 756.55151 
(0.18 ppm) were also detected with very high mass accuracy. In addition to DPPC, di-saturated (30:0, 34:0) and 
mono-unsaturated (32:1, 34:1) PCs, which are the major PC lipid species of mammalian pulmonary surfactant 
were also observed as intense peaks and detected with three different charge carriers63. Sphingomyelins are essen-
tial constituents of plasma membranes and are involved in pathogenesis of various pulmonary diseases64. Among 
the sphingomyelins, SM(34:1) was found to be highly abundant and was detected with three different charge 
carriers (Fig. 2B). Similarly, other individual lipid species, in the low m/z range various lysophospholipids were 
detected with high mass accuracy.
In negative-ion mode (Fig. 2A), important acidic phospholipids such as PG (the second most abundant phos-
pholipid class in lung surfactant), PE (abundant in whole lung tissue), other minor phospholipid classes (PA, PS, 
PI etc.), cholesterol sulfate and free fatty acids were detected and annotated based on high mass accuracy. For 
Figure 2. Single-pixel (10 µm) mass spectrum obtained from late fetal E19 mouse lung mass spectrometry 
imaging (MSI) experiments. (A) Negative-ion single-pixel mass spectrum for mass range m/z 650–850. (B) 
Positive-ion single-pixel mass spectrum for mass range m/z 700–850. Different classes of lipid species were 
identified based on high mass accuracy (≤2 ppm), labelled with measured mass and charge carrier.
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instance, intense signals at m/z 716.52386 (0.27 ppm), 760.51349 (0.13 ppm), 835.53412 (0.11 ppm), 747.51880 
(0.80 ppm), 673.48193 (0.74 ppm) were annotated as 34:1 lipid molecular species of PE, PS, PI, PG and PA lipid 
classes respectively. PG and PI lipids are synthesized from the same precursor (CDP-glycerol) and constitute up 
to 8–15% of the total surfactant phospholipid pool10. They are known to enhance the adsorption and spreading of 
DPPC over the epithelial surface63. The most intense signal in Fig. 2A at m/z 788.54498 (0.35 ppm) corresponds 
to the deprotonated PS(36:1).
Late fetal E19 (WT) mouse lung lipid ion MS images were generated using MSiReader software (jet col-
our map, linear interpolation of zero order and no normalization). Figure 3 shows selected MS images in 
negative- and positive-ion mode. Figure 3B–D show negative-ion MS images corresponding to m/z 699.49702, 
716.52386, 810.52905, annotated as [PA(36:2) − H]−, [PE(34:1) − H]− and [PS(38:4) − H]− respectively. Similarly, 
Fig. 3F–H show positive-ion MS images of m/z 818.50962, 871.71511, 741.53064, annotated as [PC(36:5) + K]+, 
[TG(50:1) + K]+ and [SM(34:1) + K]+. With our high-resolution MSI approach, various classes of phospholipids, 
glycerolipids, and sphingolipids were imaged and annotated based on accurate mass (RMSE ≤2 ppm, Tables S1 & 
S2, Fig. S2). The majority of the identified lipid species were ubiquitously distributed in the whole E19 mouse lung 
tissue sections. Due to the dense content of epithelial cells and typical fetal structure of the not yet air-inflated 
lung tissue, a homogenous lipid distribution pattern (mainly covering the peripheral region) was observed in the 
respiratory region of the E19 lung (later developing into the alveolar region of the adult lung).
On-tissue tandem mass spectrometry (MS/MS) experiments were performed to confirm the chosen lipid anno-
tations. For instance, on-tissue MS/MS analysis of potassiated SM(34:1) at m/z 741.52910 ± 0.4 resulted in diag-
nostic fragment ions at m/z 682.45550 (neutral loss of trimethylamine, 59.0736), m/z 558.46357 (neutral loss of 
phosphocholine, 183.06553), m/z 162.95622 (potassiated cyclophosphate, a characteristic fragment ion for potas-
siated PC and SM), and m/z 184.07369 (phosphocholine). Similarly, HCD activation of sodiated SM(34:1) at m/z 
725.55551 ± 0.4 yielded product ions at m/z 666.48207, m/z 542.48982 and m/z 184.07373. MS/MS analysis of proto-
nated SM(34:1) at m/z 703.57337 ± 0.4 produced the predominant fragment ion at m/z 184.07373 (phosphocholine).
MS/MS analyses of lipid species in negative-ion mode allowed assignment of individual fatty acyl (FA) chains. 
For example, fragmentation of [PE(34:1) − H]− at m/z 716.52344 ± 0.4 produced fragment ions at m/z 255.23252 
(16:0; palmitic acid) and m/z at 281.24821 (18:1; oleic acid). On-tissue MS/MS analysis of [PA(36:2) − H]− at m/z 
699.49744 ± 0.4 showed an intense fragment ion at m/z 281.24843 (18:1; oleic acid). Similarly, different classes 
of lipid species showed diagnostic fragment ions for the individual lipid class (Table S3 and MS/MS spectra in 
Supplementary Data). For example, the most intense peak in Fig. 2A, PS(36:1) at m/z 788.54397 ± 0.4 yielded a 
fragment ion at m/z 701.51242 (loss of serine, 87.03155) which is characteristic for phosphatidylserine.
Taken together, our optimized method was able to detect and characterize all possible major lipid species from 
E19 mouse lungs, based on accurate mass and on-tissue MS/MS analysis in positive- and negative-ion mode. 
This lipidomic information may aid as a reference for the lung lipidome, for a better understanding of late stage 
fetal lung development and differentiation as well as of the molecular mechanisms of various pulmonary diseases 
associated with lipid alterations.
Optimization of data processing framework for comparative lipidomics. After lipidomic charac-
terization of E19 (WT) mouse lungs, we optimized and established a data processing framework for the relative 
comparison of signal intensities of analytes in different tissue sections. A detailed scheme of the proposed data 
Figure 3. Characterization of late fetal E19 mouse lung lipidome using high-resolution AP-SMALDI mass 
spectrometry imaging experiments. (A,E) Microscopic images of E19 mouse lung. (B–D) Negative-ion MS 
images. (B) [PA(36:2) − H]−, (C) [PE(34:1) − H]−, (D) [PS(38:4) − H]−. (F–H) Positive-ion MS images. (F) 
[PC(36:5) + K]+, (G) [TG(50:1) + K]+, (H) [SM(34:1) + K]+. Scale bar 500 µm.
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processing workflow is depicted in Fig. 4. Briefly, equally thick E19 WT and Pex11β KO lung tissue sections with 
optimal morphology were analyzed on consecutive days (biological and technical replicates) with identical sam-
ple preparation, experimental and instrumental conditions. The single MS raw files were converted to imzML files 
and stitched together. Data analysis and optimization of various parameters for the relative quantification of lipids 
using MALDI MSI is described in the following sections.
Homogenous deposition of matrix. In addition to the tissue quality and thickness of the tissue sections, 
matrix deposition is another critical parameter in MSI quantification. In order to compare signal intensities of 
analytes in two different tissue (WT and KO) sections, equal concentration and homogenous deposition of matrix 
on both tissue sections is necessary. In the present study, we obtained homogenously sprayed matrix crystals on 
tissue surfaces (crystal size ≤10 µm, Fig. S3) by optimizing the flow rate of the spray syringe (10 µl/min), nitrogen 
gas (1 bar), and rotation speed of the sample probe for pNA and DHB matrices using the SMALDIPrep system 
in negative- and positive-ion mode. No washing steps were performed before matrix deposition. Homogeneous 
distribution of pNA and DHB matrix in WT and KO E19 lung tissue sections in negative- and positive-ion mode 
are illustrated in Figs 5 & S4.
Figure 5A–C show the homogeneous distribution of pNA matrix clusters (A) m/z 547.13314 [4(pNA − H)−], 
(B) m/z 427.10077 [3(pNA − H)− + H2O] and (C) m/z 273.06293 [2(pNA − H)−] between WT and KO tissue sec-
tions. Similarly, Fig. 5D–F demonstrate the homogeneous distribution of DHB matrix clusters (D) m/z 426.05815 
[3DHB-2H2O]+, (E) m/z 755.06451 [5DHB-3H2O + K]+ and (F) m/z 870.15122 [6DHB-4H2O + NH4]+ among 
WT and KO tissue sections. Uneven matrix deposition and crystallization creates artefacts in MSI, influenc-
ing signal intensities of analytes. Therefore, in our study we carefully optimized the matrix application to attain 
uniform deposition of matrix layers on both WT and KO tissue section surfaces. This enabled us to obtain 
high-quality and reproducible results from MSI for semi-quantification (relative quantification) of biomolecules. 
Recently, we showed that pneumatic spraying of matrix increases the lipid signal intensities 8-fold and 30-fold, 
compared to sublimation-recrystallization and sublimation, respectively51. In addition, reproducible MSI data 
(in terms of number and intensity of ion signals, pixel coverage and image quality) can be obtained from samples 
prepared by automated pneumatic spraying51.
In addition to matrix signals, we also detected endogenous molecules that were distributed uniformly in E19 
WT and KO lung tissue sections in negative- and positive-ion mode. For instance, Fig. 6A–C) show even distri-
bution of PE-Cer(36:1), PE(32:0) and CerP(34:1) at m/z 687.54465, 690.50793 and 616.47115 in negative-ion 
mode. Similarly, Fig. 6D–F) show positive-ion MS images of m/z 780.49386, 762.50458, 738.50443, correspond-
ing to potassiated PE(36:3), sodiated PE(36:4) and sodiated PE(34:2), respectively. Uniform distributions of 
these endogenous molecules in WT and KO were confirmed for all three charge carriers, H+, Na+ and K+ in 
positive-ion mode. Homogenous distributions of the three differently charged PE(36:4) and PE(34:2) in WT and 
KO tissue sections are demonstrated in Fig. S5.
Differential abundance of lipid species between E19 WT and Pex11β KO mouse lungs. Our 
results showed a wide variety of lipid species and other cellular metabolites that were differentially expressed 
between WT and Pex11β KO E19 mouse lung tissue sections. For instance, in KO tissue sections, deprotonated 
PG(34:1) (m/z 747.51815) showed lower signal intensities in comparison to WT (Fig. 7). Phosphatidylglycerol 
(PG) is the second most abundant phospholipid in pulmonary surfactant, with PG(34:1) being the predominant 
lipid molecular species, playing a role in adsorption, alveolar stability and innate immunity of the lungs9,10,14. 
Figure 4. Scheme of the optimized data processing framework.
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Furthermore, recent studies demonstrated that PG(34:1) (palmitoyl-oleoyl-phosphatidylglycerol, POPG) acts as 
a potent antiviral agent against influenza A and respiratory syncytial viruses13,15 as well as antagonizes the proin-
flammatory actions of mycoplasma pneumoniae65. In positive-ion mode, potassiated sulfatide lipid (SHexCer 
(t33:1), m/z 820.46415, based on MS1 annotation) showed differentially higher signal intensities in KO tissue sec-
tions compared to WT (Fig. 7). Sulfatides are multifunctional molecules, playing important roles in physiological 
processes of various organs. It has been shown that sulfatide (glycolipids) levels were elevated in many human 
cancer cells and tissues including pulmonary adenocarcinoma66. In our study, MS images clearly illustrate the 
differences in signal intensities between WT and KO lung tissues.
In addition to biological variations, several experimental and instrumental parameters may also cause var-
iations in signal intensities across different imaging datasets. Therefore, to prove the correctness of observed 
biological variations from Pex11β E19 mouse lungs and to exclude technique-dependent differences between dis-
tinct cryosections, we applied several different normalization algorithms during image generation. In our study, 
MS images were generated (1) without normalization, (2) with normalization to total ion current (TIC), (3) with 
normalization to uniformly distributed matrix cluster signals, and (4) with normalization to uniformly distrib-
uted endogenous signals. Figure 7 shows MS images of differentially abundant lipid species in WT and Pex11β 
Figure 5. Distribution of matrix cluster signals in wild type (WT) and Pex11β knockout (KO) late fetal 
E19 mouse lung tissue sections from mass spectrometry imaging (MSI) experiments. (A–C) Evenly 
distributed 4-Nitroaniline (pNA) matrix cluster images in negative-ion mode. (D–F) Evenly distributed 
2,5-Dihydroxybenzoic acid (DHB) matrix cluster images in positive-ion mode. Scale bar 500 µm.
Figure 6. Homogenous distribution of endogenous compounds in wild type (WT) and PEX11β knockout 
(KO) late fetal E19 mouse lung tissue sections, measured by atmospheric-pressure MALDI MSI experiments. 
(A-C) Evenly distributed lipid species in negative-ion mode. (A) [PE-Cer(36:1) − H]−, (B) [PE(32:0) − H]− and 
(C) [CerP(34:1) − H]−. (D–F) Evenly distributed lipid species in positive-ion mode. (D) [PE(36:3) + K]+, (E) 
[PE(36:4) + Na]+ and (F) [PE(34:2) + Na]+. Scale bar 500 µm.
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KO tissue sections, generated with various normalization algorithms. Regardless of the normalization method, 
our MSI data was found to be consistent, and normalization approaches did not induce significant changes in 
the determined differential abundance of lipid species in both ionization modes, proving the high quality of our 
optimized protocol used (Fig. 7 & Table S4).
Normalization is defined as a process of projecting all data to a common intensity scale for the comparison 
of spectra67,68. Many normalization strategies have been described in literature to correct the variations in signal 
intensities of MSI data such as TIC, root mean square (RMS), median intensity, vector normalization, normali-
zation to matrix signals, endogenous signals, stable isotope standards, tissue-specific ionization efficiency coef-
ficient and sliding window normalization, etc.67–71. Each strategy has its own limitations, a number of them are 
Figure 7. Differential abundance of lipid species in wild type (WT) and Pex11β knockout (KO) late fetal E19 
mouse lung tissue sections in negative- and positive-ion mode. Downregulation of [PG(34:1) − H]− lipid (m/z 
747.51815), upregulation of [SHexCer(t33:1) + K]+ lipid (m/z 820.46415) in Pex11β KO E19 mouse lungs 
in negative- and positive-ion mode. The abundance comparisons between lipids in different cryosections 
were verified by applying various normalization algorithms: (i) no normalization, (ii) total ion count (TIC) 
normalization, (iii) normalization to homogenously distributed matrix signals and (iv) normalization to 
homogenously distributed endogenous signals. Scale bar 500 µm.
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reviewed in detail in the context of quantification (relative and absolute) of low molecular weight compounds by 
MALDI MSI71.
TIC normalization is the most common method, and several studies demonstrated uniformly distributed 
matrix cluster and/or endogenous signals as “internal-standard-like” normalization for semi-quantitative analysis 
by MALDI MSI68. In many cases, normalization, interpolation and other post-processing parameters influence 
signal intensities of analytes in MSI, which often leads to wrong interpretations of the data. In such cases, it is 
challenging to draw reliable biological conclusions from MSI data, especially in the case of biomarker studies and 
pharmaceutical applications (drug discovery). Therefore, we optimized the sample preparation, experimental 
and instrumental conditions, and our data processing framework very carefully to produce highly accurate and 
reproducible MSI data for a direct relative comparison of signal intensities of analytes.
The differential abundance of lipid species in WT and KO tissue sections was confirmed using biological rep-
licates (Fig. S6). For instance, deprotonated PG (34:1) and potassiated SHexCer (t33:1) showed similar trends of 
differential abundance between WT and KO tissue sections of different animals (n = 3).
Confirmation of differential abundance of lipids with various ion adducts. Differential abundance 
of lipid species in WT and KO tissue sections was also confirmed based on various ionic species in positive-ion 
mode. For instance, the lysophosphatidylcholines LPC(14:0) and LPC(16:0) exhibited reduced signal intensities 
in KO lung tissue sections compared to WT. LPCs are lipid mediators produced from PCs by the action of phos-
pholipase A2 (PLA2), and involved in various pro-inflammatory and pro-atherogenic activities72. The observed 
differential pattern was found to be consistent in protonated, sodiated and potassiated ionic state. Figure 8 shows 
MS images of LPC(14:0) [(A) 468.30846, (B) 490.29041 and (C) 506.26434] and LPC(16:0) [(D) 496.33976, (E) 
518.32171 and (F) 534.29564], containing the three different charge carriers, respectively.
Structural confirmation of lipid species using on-tissue tandem mass spectrometry (MS/MS). 
The web-based “MetFrag” server was used to generate possible fragment ions of the lipid species73. The theoretical 
fragments generated by the software were identical to the fragments observed in our experiments. Annotation of 
differentially abundant lipids was further confirmed based on on-tissue tandem mass spectrometry experiments. 
For instance, deprotonated PG(34:1) (POPG) at m/z 747.51966 ± 0.4 was structurally confirmed with fragment 
ions at m/z 152.99460 (corresponding to the cyclic phosphate anion, red), m/z 255.23307 (corresponding to pal-
mitic fatty acyl (FA 16:0), green), and m/z 281.24885 (corresponding to oleic fatty acyl (FA 18:1), blue) (Fig. 9A).
In positive-ion mode, protonated LPC(16:0) at m/z 496.34007 ± 0.4 was structurally confirmed using frag-
ment ions at m/z 104.10758 (corresponding to choline, red), m/z 184.07364 (corresponding to phosphocho-
line head group, green), and m/z 478.32943 (corresponding to the loss of water [M + H-H2O]+, blue) (Fig. 9B). 
Similarly, sodiated and potassiated species were also confirmed with characteristic fragmentation patterns from 
both WT and KO tissue sections (Supplementary Data & Table S3).
Conclusion
We report a comprehensive lipid map of late fetal WT mouse lungs at day 19 of gestation (E19) using high-resolution 
accurate mass AP-SMALDI MSI. We demonstrated optimized experimental and instrumental conditions as well as 
a detailed data processing framework for comparative analysis of biomolecules in different tissue sections of WT 
and KO mice (using the Pex11β KO mouse here as a model system). The optimized workflow will be useful for 
relative (semi-) quantitative analyses of lipids and other cellular metabolites from different tissue sections using 
MALDI MSI. Highly specific and accurate lipidomic information of late fetal stage E19 mouse lungs may serve as 
Figure 8. Confirmation of differential abundance of lipid species in wild type (WT) and Pex11β knockout (KO) 
late fetal E19 mouse lung tissue sections for various charge carriers in positive-ion mode. (A–C) Differential 
abundance of LPC(14:0) in WT and KO E19 mouse lung tissue. (A) [LPC(14:0) + H]+, (B) [LPC(14:0) + Na]+, 
(C) [LPC(14:0) + K]+. (D–F) Differential abundance of LPC(16:0) in WT and KO E19 mouse lung tissue. (D) 
[LPC(16:0) + H]+, (E) [LPC(16:0) + Na]+, (F) [LPC(16:0) + K]+. Scale bar 500 µm.
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a reference for better understanding of lung developmental processes (e.g. late fetal differentiation) or molecular 
mechanisms of various pulmonary diseases, associated with lipid alterations.
Materials and Methods
Materials. Trifluoroacetic acid (TFA, spectroscopy grade), 2,5-Dihydroxybenzoic acid (DHB, 98% purity) and 
acetone (spectroscopy grade) were purchased from Merck (Darmstadt, Germany). 4-Nitroaniline (pNA, ≥99% 
purity) and water (LC-MS grade) were procured from Sigma-Aldrich (Steinheim, Germany). Glass microscope 
slides (ground edges, SuperFrost) were obtained from R. Langenbrinck (Emmendingen, Germany). All other 
reagents used were of highest purity and analytical grade.
Animal experiments. Specific-pathogen-free (SPF) C57BL/6J mice were obtained from Charles River, 
Sulzfeld, Germany. Mice were kept on a regular laboratory diet and water ad libitum and housed in cages under 
standardized environmental conditions (12 hours light/dark cycle, 23 °C ± 1 °C and 55% ± 1% relative humidity). 
Generation and breeding of Pex11β knockout (KO) mice were described previously53,54. Pregnant dames with 
eventual Pex11β KO mice (autosomal-recessive inheritance with 25% WT, 50% Pex11β HTZ, and 25% Pex11β 
KO) were kept in the SPF central animal facility of Justus Liebig University Giessen, Germany. Pregnant dames 
were killed by cervical dislocation and the E19 fetus were killed by decapitation.
“Experiments were approved by the named animal welfare officers of the Justus Liebig University (administra-
tive number M471) and performed according to the German and European animal welfare law”.
Sample (E19 mouse lung tissue) preparation for MSI. For the perfusion of the E19 mouse lungs, 
the skin of the pups was opened, the right ventricle of the heart was punctured with an 18-size gauze needle. 
Thereafter, the left atrium was cut open and the animals were perfused via the right ventricle with 500 μl of saline. 
After the saline wash, lung tissues were perfused with 10 ml of a 4% paraformaldehyde (PFA) fixative in phosphate 
buffer saline (PBS), pH 7.4. Thereafter, the lungs were excised and further fixed from the outside by overnight 
immersion fixation. The PFA fixed lung tissues were embedded with the optimal cutting temperature (OCT) com-
pound. Twelve µm thick cryosections were cut with a cryomicrotome (CM 3050 S cryostat, Leica Microsystems, 
Nussloch, Germany) and stored at −80 °C until further use.
Later, we optimized a sectioning procedure for fresh snap-frozen E19 mouse lung tissues without using any 
embedding material. For cryosectioning, fresh frozen E19 lung tissues were mounted directly on a sample holder 
of the cryotome, using deionized water (ice) as an adhesive. For MSI experiments, both WT and Pex11β KO E19 
mouse lung tissue, serial sections were cut with an equal thickness of 12 µm at −20 °C with a cryomicrotome (CM 
3050 S cryostat, Leica Microsystems, Nussloch, Germany). One section of a series was thaw-mounted on each 
glass microscope slide (ground edge, SuperFrost) and labelled with an appropriate number for later identification. 
For the purpose to get an overview on the quality and thickness of each entire cryosection, several overlapping 
images covering the whole tissue section were taken at a magnification of 40x with a Leica DMRD microscope 
(Leica, Bensheim, Germany) equipped with a Leica DC 480 camera (Leica, Bensheim, Germany) and thereafter 
stitched together with Image composite editor (Microsoft Research). Identical camera settings were used to be able 
to compare the darkness and grey values of all cut cryosections to optimize the selection procedure for high qual-
ity sections with similar section thicknesses. Care was taken to speed up the image taking procedure of each indi-
vidual section. All other sections were stored in parallel prior to and after photographing in a slide box on dry ice. 
Figure 9. Structural confirmation of lipid annotations by on-tissue tandem mass spectrometry (MS/MS) in 
negative- and positive-ion mode, using high-energy collisional dissociation (HCD). (A) On-tissue HCD-MS/
MS (averaged) spectrum of [PG(34:1) − H]− m/z 747.51966 ± 0.4. (B) On-tissue HCD-MS/MS (averaged) 
spectrum of [LPC(16:0) + H]+ m/z 496.34007 ± 0.4.
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The best and optimally matched lung cryosections of the appropriate WT and KO animals were either used 
directly for immediate MS imaging experiments or stored at −80 °C until further analysis on consecutive days for 
replicate measurements.
Matrix application. Prior to matrix application, the frozen lung tissue sections were brought to room tem-
perature in a desiccator (about 15 minutes) to avoid condensation of humidity on the surface of the samples. DHB 
(30 mg mL−1 in acetone:water at 1:1 vol/vol, 0.1% TFA), and pNA (10 mg mL−1 in acetone:water at 1:1 vol/vol) 
solutions were prepared freshly for the matrix application. For positive-ion mode measurements, a volume of 
120 µL of DHB, for negative-ion mode a volume of 50 µL of pNA matrix solution were deposited homogeneously 
on the tissue surfaces by using an automatic pneumatic ultrafine sprayer (“SMALDIPrep”, TransMIT GmbH, 
Giessen, Germany)74.
MALDI mass spectrometry imaging. Immediately after matrix application, MSI experiments were per-
formed using a high-resolution atmospheric-pressure scanning microprobe matrix-assisted laser desorption/
ionization ion source (“AP-SMALDI10”, TransMIT GmbH, Giessen, Germany), coupled to a Fourier transform 
orbital trapping mass spectrometer (Q Exactive, Thermo Scientific GmbH, Bremen, Germany)75. Desorption and 
ionization of analytes were initiated by a nitrogen gas laser (LTB Lasertechnik GmbH, Berlin, Germany) with a 
wavelength of 337 nm, operating at a repetition rate of 60 Hz. The laser beam was focused coaxially with the ion 
beam by a centrally bored objective lens76. In all the MALDI MSI experiments, the E19 mouse lung tissue sections 
were measured with high resolution in mass (140,000 @ m/z 200) and space (10 µm per pixel). The step size of 
the sample stage was set to the desired pixel size (10 µm). The mass spectrometer was operated in positive- and 
negative-ion mode in the mass to charge number (m/z) range of m/z 250–1000 with a target voltage of +/−4.3 kV. 
Automatic gain control (AGC) was disabled, and the injection time (IT) was fixed at 500 ms (microscans = 1). The 
measurement speed in full scan mode (scan range m/z 250–1000) was about 0.8 pixels per second at a mass resolu-
tion of 140,000 (at m/z 200). Ions formed by 30 laser pulses per spot were accumulated in the C-trap before being 
sent to the orbitrap mass analyser for detection. Internal mass calibration was performed using known matrix ion 
signals as lock mass values (716.12462 and 409.09020 for positive- and negative-ion mode, respectively), which 
resulted in a mass accuracy better than 2 ppm root mean square error (RMSE) over the entire measurement.
Annotation of lipid species. Lipid species were annotated according to the proposal for shorthand nota-
tion of lipid structures derived from mass spectrometry77. For instance, phospholipid species (e.g. PC, PG, PI, 
etc.) were denoted as (X:Y), where X represents the total number of carbon atoms and Y represents the total num-
ber of double bonds in fatty acyl chains, without specifying the individual acyl chains attached to the glycerol or 
sphingosine backbone. In sphingolipids, “m”, “d” and “t” represents the number of hydroxyl groups in sphingoid 
base (mono, di, and tri)77.
Data processing and image generation. AP-SMALDI MSI data sets (.raw) were converted to cen-
troid imzML files, and E19 mouse lung lipid ion MS images were generated using the open source software 
“MSiReader” version 0.0978 with a m/z bin width of Δ m/z = ±5 ppm. No further (pre or post) data process-
ing steps were applied for image generation in order to demonstrate the original data quality. The lipid spe-
cies were annotated based on accurate ion mass (m/z) values, by using databases such as LIPID MAPS (www.
lipidmaps.org), METLIN (www.metlin.scripps.edu) and Human Metabolite Database (www.hmdb.ca) within Δ 
m/z = ±2 ppm or 0.0005 Da. In negative-ion mode, deprotonated [M − H]−, in positive-ion mode protonated 
[M + H]+, sodiated [M + Na]+ and potassiated [M + K]+ species were considered for the annotation.
After characterization of the lipidome of E19 mouse lungs, signal intensities of lipid species were compared 
between E19 WT and Pex11β KO mouse lung tissue sections using the same software (MSiReader v0.09). Images 
were generated with a bin width of Δ m/z = ±5 ppm. Pre-processing steps, such as baseline correction, noise 
removal, smoothing or interpolation, were not applied during image generation. Normalization of signal inten-
sities was performed in the following alternative ways: (1) no normalization, (2) total ion current (TIC) normali-
zation, (3) normalization with ubiquitous matrix signals, (4) normalization with ubiquitous endogenous signals, 
or (5) specific strategies for comparison of relative ion abundances in WT and KO E19 lung tissue sections. These 
procedures are explained in detail in the results and discussion section.
On-tissue MS/MS analysis. Lipid annotation based on accurate ion mass (≤2 ppm) was further confirmed 
by on-tissue tandem mass spectrometry (MS/MS) analysis. MS/MS fragmentation was performed by using 
higher-energy collisional dissociation (HCD) with a precursor ion isolation window of 0.4 Da. Fragmentation of 
individual lipid species was obtained with normalized collision energy values (NCE) of 20–28% (averaged spectra 
from 20, 25 and 28 NCE) and 15–25% (averaged spectra from 15, 20 and 25 NCE) in positive- and negative-ion 
mode, respectively. The experimental fragmentation patterns of lipids were confirmed based on neutral losses, 
diagnostic fragment ions of the head groups79, by matching with tandem MS spectra of standard lipid species 
available in databases (e.g. METLIN, HMDB, etc.), or by comparing with the in-silico fragmentation patterns 
using MetFrag web server73.
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